Patent details

EP2222315 Title: STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE

Basic Information

Publication number:
EP2222315
PCT Application Number:
PCT/US/2008/087031
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP088646468
PCT Publication Number:
WO/2009/082648
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE
French Title of Invention:
FORMULATIONS STABILISÉES DE FACTEUR IX CONTENANT DU TRÉHALOSE
German Title of Invention:
STABILISIERTE FAKTOR-IX-FORMULIERUNGEN MIT TREHALOSE
SPC Number:

Dates

Filing date:
16/12/2008
Grant date:
24/04/2013
EP Publication Date:
24/04/2013
PCT Publication Date:
02/07/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/09/2010
EP B1 Publication Date:
24/04/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
16/12/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/02/2018
 
 

Name:
Aptevo BioTherapeutics LLC
Address:
2401 4th Avenue, Suite 1050, Seattle WA 98121, United States (US)

History of Owners

From:
14/02/2018
To:
14/02/2018

Name:
407850 Manitoba Partnership
Address:
c/o Aikins & Co LLP, 360 Main Street, 30th Floor, Winnipeg, R3C 4G1, Canada (CA)

From:
14/02/2018
To:
14/02/2018

Name:
Cangene Corporation
Address:
115 Innovation Drive, Winnipeg, Manitoba R3T 5Y3, Canada (CA)

From:
24/06/2014
To:
14/02/2018

Name:
CNJ HOLDINGS INC
Address:
155 Innovation Drive, Winnipeg, MB R3T 5Y3, Canada (CA)

From:
16/12/2008
To:
23/06/2014

Name:
CANGENE CORPORATION
Address:
INNOVATION DRIVE 115, WINNIPEG, MANITOBA R3T 5Y3, Canada (CA)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/06/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
GRIFFITH Michael, J.
Address:
United States (US)

2

Name:
MANKARIOUS Samia
Address:
United States (US)

Priority

Priority Number:
16230 P
Priority Date:
21/12/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 35/14;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:
CO
Bulletin edition number:
2018/04
Publication date:
23/03/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000049A
Date Registered:
14/02/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Office FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Cangene Corporation
Address:
115 Innovation Drive, Winnipeg, Manitoba R3T 5Y3, Canada (CA)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000050A
Date Registered:
14/02/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Office FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
407850 Manitoba Partnership
Address:
c/o Aikins & Co LLP, 360 Main Street, 30th Floor, Winnipeg, R3C 4G1, Canada (CA)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000051A
Date Registered:
14/02/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
Office FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Aptevo BioTherapeutics LLC
Address:
2401 4th Avenue, Suite 1050, Seattle WA 98121, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
31/12/2025
Annual Fee Number:
18
Annual Fee Amount:
262 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/12/2024
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
14/02/2018 Request For Change 6
14/02/2018 Request For Change 12
26/02/2018 Outgoing Correspondence 1
14/02/2018 Request For Change 14
26/02/2018 Outgoing Correspondence 1